Zobrazeno 1 - 10
of 74
pro vyhledávání: '"William Wierda"'
Autor:
Ti’ara L. Griffen, Fieke W. Hoff, Yihua Qiu, James W. Lillard, Alessandra Ferrajoli, Philip Thompson, Endurance Toro, Kevin Ruiz, Jan Burger, William Wierda, Steven M. Kornblau
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 3, Pp 1-14 (2022)
Abstract Protein expression for 384 total and post-translationally modified proteins was assessed in 871 CLL and MSBL patients and was integrated with clinical data to identify strategies for improving diagnostics and therapy, making this the largest
Externí odkaz:
https://doaj.org/article/db77fb9301b64bc0981763c122e79287
Autor:
Fieke W. Hoff, Ti’ara L. Griffen, Brandon D. Brown, Terzah M. Horton, Jan Burger, William Wierda, Stefan E. Hubner, Yihua Qiu, Steven M. Kornblau
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 6, p 5460 (2023)
DNA damage response (DNADR) recognition and repair (DDR) pathways affect carcinogenesis and therapy responsiveness in cancers, including leukemia. We measured protein expression levels of 16 DNADR and DDR proteins using the Reverse Phase Protein Arra
Externí odkaz:
https://doaj.org/article/cedf8a088b1f418ea816592f9acb110d
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 6, p 5481 (2023)
Proteomic DNA Damage Repair (DDR) expression patterns in Chronic Lymphocytic Leukemia were characterized by quantifying and clustering 24 total and phosphorylated DDR proteins. Overall, three protein expression patterns (C1-C3) were identified and we
Externí odkaz:
https://doaj.org/article/d35a4dc9e64540659741b7aaa79512a4
Autor:
Alejandro Zulbaran‐Rojas, Huei‐Kan Lin, Qiuling Shi, Loretta A. Williams, Binsah George, Guillermo Garcia‐Manero, Elias Jabbour, Susan O’Brien, Farhad Ravandi, William Wierda, Zeev Estrov, Gautam Borthakur, Tapan Kadia, Charles Cleeland, Jorge E. Cortes, Hagop Kantarjian
Publikováno v:
Cancer Medicine, Vol 7, Iss 11, Pp 5457-5469 (2018)
Abstract Background Treatment with tyrosine kinase inhibitors (TKIs) for patients with chronic myeloid leukemia (CML) is effective but needs to continue for several years, possibly indefinitely. Although generally safe, TKI may have hitherto poorly r
Externí odkaz:
https://doaj.org/article/2ed63f7978de4961a377b3b77147ee63
Autor:
Prajwal Boddu, Gautam Borthakur, Mythili Koneru, Xuelin Huang, Kiran Naqvi, William Wierda, Prithviraj Bose, Elias Jabbour, Zeev Estrov, Jan Burger, Yesid Alvarado, April Deshmukh, Ami Patel, Antonio Cavazos, Lina Han, Jorge E. Cortes, Hagop Kantarjian, Michael Andreeff, Marina Konopleva
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Background: The CXCR4/SDF-1α axis plays a vital role in the retention of stem cells within the bone marrow and downstream activation of cell survival signaling pathways. LY2510924, a second generation CXCR4, showed significant anti-leukemia activity
Externí odkaz:
https://doaj.org/article/c2ad7be1c5364b8ebd00f91dd7c3247a
Autor:
Simon Schliffke, Mariela Sivina, Ekaterina Kim, Lisa von Wenserski, Benjamin Thiele, Nuray Akyüz, Clemens Falker-Gieske, Donjete Statovci, Anna Oberle, Toni Thenhausen, Artus Krohn-Grimberghe, Carsten Bokemeyer, Nitin Jain, Zeev Estrov, Alessandra Ferrajoli, William Wierda, Michael Keating, Jan A. Burger, Mascha Binder
Publikováno v:
OncoImmunology, Vol 7, Iss 4 (2018)
Using next-generation immunoglobulin (IGH) sequencing and flow cytometry, we characterized the composition, diversity and dynamics of non-malignant B cells in patients undergoing treatment with the Bruton tyrosine kinase (BTK) inhibitor ibrutinib or
Externí odkaz:
https://doaj.org/article/a65454febf2744a291d53103ae94dc11
Autor:
Hila Shaim, Zeev Estrov, David Harris, Mayra Hernandez Sanabria, Zhiming Liu, Peter Ruvolo, Phillip A. Thompson, Alessandra Ferrajoli, May Daher, Jan Burger, Muharrem Muftuoglu, Nobuhiko Imahashi, Li Li, Enli Liu, Abdullah Saleh Alsuliman, Rafet Basar, Lucila Nassif Kerbauy, Catherine Sobieski, Elif Gokdemir, Kayo Kondo, William Wierda, Michael Keating, Elizabeth J. Shpall, Katayoun Rezvani
Publikováno v:
Frontiers in Immunology, Vol 8 (2018)
Chronic lymphocytic leukemia (CLL) cells possess regulatory functions comparable to those of normal B10 cells, a regulatory B cell subset that suppresses effector T-cell function through STAT3-mediated IL-10 production. However, the mechanisms govern
Externí odkaz:
https://doaj.org/article/e083fa30bf44444692ed076413c733b3
Autor:
Nitin Jain, Xinyan Lu, Naval Daver, Beenu Thakral, Sa A. Wang, Sergej Konoplev, Keyur Patel, Rashmi Kanagal-Shamanna, Marcus Valentine, Guilin Tang, Naveen Pemmaraju, Jeffrey Jorgensen, Partow Kebriaei, Cesar A. Nunez, William Wierda, Elias Jabbour, Kathryn G. Roberts, Charles G. Mullighan, Hagop Kantarjian, Marina Konopleva
Publikováno v:
Haematologica, Vol 102, Iss 12 (2017)
Externí odkaz:
https://doaj.org/article/26e18557719e4510accaecd44b4d2025
Autor:
Koji Sasaki, Hagop Kantarjian, Elias Jabbour, Farhad Ravandi, Koichi Takahashi, Marina Konopleva, Gautam Borthakur, Guillermo Garcia-Manero, William Wierda, Naval Daver, Preetesh Jain, Toshihisa Satta, Sherry Pierce, May Beth Rios, Jorge E. Cortes
Publikováno v:
Haematologica, Vol 101, Iss 8 (2016)
Externí odkaz:
https://doaj.org/article/bb9ce6808f794b4384e227e460dd8ac5
Autor:
Naveen Pemmaraju, Hagop Kantarjian, Jianqin Shan, Elias Jabbour, Alfonso Quintas-Cardama, Srdan Verstovsek, Farhad Ravandi, William Wierda, Susan O’Brien, Jorge Cortes
Publikováno v:
Haematologica, Vol 97, Iss 7 (2012)
Background Outcomes in chronic myeloid leukemia have improved with tyrosine kinase inhibitor treatment. However, little is known about outcomes of chronic myeloid leukemia in adolescent and young adult patients.Design and Methods We reviewed all 468
Externí odkaz:
https://doaj.org/article/b3ea3e9ade2449fc9c8c00e34ef2eac6